Drug delivery technology company Midatech Pharma said it had raised £4.3m combined from a UK share placing and separate issue of American depository shares.
Cancer treatment and vaccine delivery system developer N4 Pharma said it was filing ongoing patent applications in seven territories for its Nuvec technology.
Schroder AsiaPacific Fund posted a negative first-half performance that missed its benchmark, following a sharp drop in markets owing to the Covid-19 pandemic.